UBS, New York Branch
Lily guides biotechnology companies in the negotiation of complex product development and commercialization transactions and uses her extensive experience to arrive at pragmatic, client-driven solutions. She advises early and mid-stage companies, many in the cell and gene-therapy space and assists both drug sponsors and contract development and manufacture organizations, with supply-chain documentation for clinical and commercial manufacture and supply arrangements for both biologics and small molecules. Lily also represents public and private companies in strategic collaborations, product licensing, and distribution and co-promotion agreements.
Lily is Chairperson of the firm’s Equity, Diversity and Inclusion Committee.
New York Branch of UBS
Director and Counsel
Simpson Thacher & Bartlett
Corporate Department Associate
Member of business transactions group